Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Portal Instruments Inc. is currently managing 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These pending office actions are distributed among 3 distinct examiners, yet all are concentrated within 1 distinct art unit. William R Carpenter is the busiest examiner for the company, handling 1 pending office action.
The concentration of pending office actions in 1 distinct art unit suggests that the company's current patent pursuits are technically focused within a specific niche of Medical Devices & Mechanical Engineering. However, the involvement of the distinct examiners means that the company must navigate different individual review styles. William R Carpenter is one of these examiners, managing a portion of the workload.
For a practitioner, this profile indicates that while the technical field is narrow, the prosecution risk is spread across multiple examiners. Each of the 3 pending office actions is being evaluated by a different official. William R Carpenter's role as the busiest examiner is shared with others, as he only manages a single action.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CARPENTER, WILLIAM R | 1 | 54.4% | +52.6% |
| TRINH, HONG-VAN N | 1 | 62.8% | +57.0% |
| STIGELL, THEODORE J | 1 | 78.3% | +14.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17025768 | NEEDLE-FREE INJECTOR FOR LARGE-SCALE, MULTI-DOSE APPLICATIONS | STIGELL, THEODORE J | 13d |
| 18229219 | Needle-free Transdermal Injection Device | TRINH, HONG-VAN N | 26d |
| 18422710 | CONNECTED HEALTH PLATFORM INCLUDING NEEDLE-FREE INJECTOR SYSTEM | CARPENTER, WILLIAM R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17025768 | NEEDLE-FREE INJECTOR FOR LARGE-SCALE, MULTI-DOSE APPLICATIONS | STIGELL, THEODORE J | 13d |
| 18229219 | Needle-free Transdermal Injection Device | TRINH, HONG-VAN N | 26d |
| 18422710 | CONNECTED HEALTH PLATFORM INCLUDING NEEDLE-FREE INJECTOR SYSTEM | CARPENTER, WILLIAM R | — |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18422710 | CONNECTED HEALTH PLATFORM INCLUDING NEEDLE-FREE INJECTOR SYSTEM | CARPENTER, WILLIAM R | 3783 | §103§112Other | Final Rejection | — | Pending | Jan 25, 2024 |
| 18229219 | Needle-free Transdermal Injection Device | TRINH, HONG-VAN N | 3783 | §103§112 | Final Rejection | 26d | Pending | Aug 02, 2023 |
| 17025768 | NEEDLE-FREE INJECTOR FOR LARGE-SCALE, MULTI-DOSE APPLICATIONS | STIGELL, THEODORE J | 3783 | §103§112 | Final Rejection | 13d | Pending | Sep 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial